Global Pharma Grade Isosorbide Market Growth 2025-2031

Publication ID:

LPI05253131

Publication Date:

May 9, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Pharma Grade Isosorbide market size is predicted to grow from US$ 65.1 million in 2025 to US$ 77.7 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031.
Pharmaceutical Grade Isosorbide is a high-purity chemical substance used in the pharmaceutical field. Isosorbide is a diol extracted from plant-derived materials (such as corn starch) and belongs to cyclic sugar alcohols. It has good biocompatibility and biodegradability. In the pharmaceutical field, isosorbide and its derivatives are used to produce drugs for the treatment of cardiovascular diseases, with good drug activity and safety. At the same time, isosorbide is also an effective osmotic oral dehydration diuretic.
The global pharmaceutical-grade isosorbide market is entering a period of steady growth, and the compound annual growth rate is expected to reach 2.88% in the next five years. This trend is mainly driven by two aspects: first, the rising incidence of chronic diseases such as cardiovascular diseases and neurological diseases has driven the growth of demand for core APIs such as isosorbide dinitrate; second, the research and development of innovative drugs is hot, and its technical value as a chiral intermediate in the development of controlled-release preparations and targeted drugs is highlighted. At the same time, the strict standards of the global pharmaceutical industry for the purity and stability of APIs have further strengthened the market barriers and premium space for high-purity pharmaceutical-grade products. From the perspective of regional distribution, Europe and China dominate the global supply of pharmaceutical-grade isosorbide. Europe occupies most of the market share with its mature bio-based chemical industry chain. As an industry benchmark, Roquette, a French company, has long served the supply chain of multinational pharmaceutical companies by relying on continuous production processes and cGMP certification systems. China has risen rapidly through policy support and capacity upgrades. Local companies such as Yuteng Pharmaceuticals have broken through the bottleneck of high-purity purification technology and built a thousand-ton pharmaceutical-grade production line. Its cost advantage and localized service capabilities have gradually opened up the high-end market in Europe and the United States. The main consumer market for pharmaceutical-grade products is relatively scattered, and there is demand in all countries around the world. Among them, the countries with greater demand include China, India, Japan, the United States, Europe and other developed pharmaceutical markets.
The 鈥淧harma Grade Isosorbide Industry Forecast鈥� looks at past sales and reviews total world Pharma Grade Isosorbide sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharma Grade Isosorbide sales for 2025 through 2031. With Pharma Grade Isosorbide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma Grade Isosorbide industry.
This Insight Report provides a comprehensive analysis of the global Pharma Grade Isosorbide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharma Grade Isosorbide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharma Grade Isosorbide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma Grade Isosorbide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma Grade Isosorbide.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharma Grade Isosorbide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
99.5%
99%
Segmentation by Application:
Cardiovascular Drugs
Dehydration Diuretics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roquette
Yu Teng
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharma Grade Isosorbide market?
What factors are driving Pharma Grade Isosorbide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharma Grade Isosorbide market opportunities vary by end market size?
How does Pharma Grade Isosorbide break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharma Grade Isosorbide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pharma Grade Isosorbide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pharma Grade Isosorbide by Country/Region, 2020, 2024 & 2031
2.2 Pharma Grade Isosorbide Segment by Type
2.2.1 99.5%
2.2.2 99%
2.3 Pharma Grade Isosorbide Sales by Type
2.3.1 Global Pharma Grade Isosorbide Sales Market Share by Type (2020-2025)
2.3.2 Global Pharma Grade Isosorbide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pharma Grade Isosorbide Sale Price by Type (2020-2025)
2.4 Pharma Grade Isosorbide Segment by Application
2.4.1 Cardiovascular Drugs
2.4.2 Dehydration Diuretics
2.4.3 Others
2.5 Pharma Grade Isosorbide Sales by Application
2.5.1 Global Pharma Grade Isosorbide Sale Market Share by Application (2020-2025)
2.5.2 Global Pharma Grade Isosorbide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pharma Grade Isosorbide Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pharma Grade Isosorbide Breakdown Data by Company
3.1.1 Global Pharma Grade Isosorbide Annual Sales by Company (2020-2025)
3.1.2 Global Pharma Grade Isosorbide Sales Market Share by Company (2020-2025)
3.2 Global Pharma Grade Isosorbide Annual Revenue by Company (2020-2025)
3.2.1 Global Pharma Grade Isosorbide Revenue by Company (2020-2025)
3.2.2 Global Pharma Grade Isosorbide Revenue Market Share by Company (2020-2025)
3.3 Global Pharma Grade Isosorbide Sale Price by Company
3.4 Key Manufacturers Pharma Grade Isosorbide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharma Grade Isosorbide Product Location Distribution
3.4.2 Players Pharma Grade Isosorbide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pharma Grade Isosorbide by Geographic Region
4.1 World Historic Pharma Grade Isosorbide Market Size by Geographic Region (2020-2025)
4.1.1 Global Pharma Grade Isosorbide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pharma Grade Isosorbide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pharma Grade Isosorbide Market Size by Country/Region (2020-2025)
4.2.1 Global Pharma Grade Isosorbide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pharma Grade Isosorbide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharma Grade Isosorbide Sales Growth
4.4 APAC Pharma Grade Isosorbide Sales Growth
4.5 Europe Pharma Grade Isosorbide Sales Growth
4.6 Middle East & Africa Pharma Grade Isosorbide Sales Growth
5 Americas
5.1 Americas Pharma Grade Isosorbide Sales by Country
5.1.1 Americas Pharma Grade Isosorbide Sales by Country (2020-2025)
5.1.2 Americas Pharma Grade Isosorbide Revenue by Country (2020-2025)
5.2 Americas Pharma Grade Isosorbide Sales by Type (2020-2025)
5.3 Americas Pharma Grade Isosorbide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharma Grade Isosorbide Sales by Region
6.1.1 APAC Pharma Grade Isosorbide Sales by Region (2020-2025)
6.1.2 APAC Pharma Grade Isosorbide Revenue by Region (2020-2025)
6.2 APAC Pharma Grade Isosorbide Sales by Type (2020-2025)
6.3 APAC Pharma Grade Isosorbide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharma Grade Isosorbide by Country
7.1.1 Europe Pharma Grade Isosorbide Sales by Country (2020-2025)
7.1.2 Europe Pharma Grade Isosorbide Revenue by Country (2020-2025)
7.2 Europe Pharma Grade Isosorbide Sales by Type (2020-2025)
7.3 Europe Pharma Grade Isosorbide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharma Grade Isosorbide by Country
8.1.1 Middle East & Africa Pharma Grade Isosorbide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pharma Grade Isosorbide Revenue by Country (2020-2025)
8.2 Middle East & Africa Pharma Grade Isosorbide Sales by Type (2020-2025)
8.3 Middle East & Africa Pharma Grade Isosorbide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharma Grade Isosorbide
10.3 Manufacturing Process Analysis of Pharma Grade Isosorbide
10.4 Industry Chain Structure of Pharma Grade Isosorbide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharma Grade Isosorbide Distributors
11.3 Pharma Grade Isosorbide Customer
12 World Forecast Review for Pharma Grade Isosorbide by Geographic Region
12.1 Global Pharma Grade Isosorbide Market Size Forecast by Region
12.1.1 Global Pharma Grade Isosorbide Forecast by Region (2026-2031)
12.1.2 Global Pharma Grade Isosorbide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pharma Grade Isosorbide Forecast by Type (2026-2031)
12.7 Global Pharma Grade Isosorbide Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roquette
13.1.1 Roquette Company Information
13.1.2 Roquette Pharma Grade Isosorbide Product Portfolios and Specifications
13.1.3 Roquette Pharma Grade Isosorbide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roquette Main Business Overview
13.1.5 Roquette Latest Developments
13.2 Yu Teng
13.2.1 Yu Teng Company Information
13.2.2 Yu Teng Pharma Grade Isosorbide Product Portfolios and Specifications
13.2.3 Yu Teng Pharma Grade Isosorbide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Yu Teng Main Business Overview
13.2.5 Yu Teng Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂